carcinoma, squamous cell of head and neck
Showing 1 - 25 of 40
Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)
Not yet recruiting
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- disitamab vedotin
- (no location specified)
Aug 15, 2023
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,
Active, not recruiting
- Cancer of Head and Neck
- +5 more
- MK-3475 (neoadjuvant)
- +6 more
-
Boston, Massachusetts
- +2 more
Dec 9, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- PD 0332991
-
Atlanta, Georgia
- +4 more
Nov 1, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- +2 more
-
Darmstadt, GermanyResearch site
Apr 19, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Nimotuzumab, Placebo)
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Nimotuzumab
- Placebo
-
Bedford Park, Australia
- +29 more
Apr 4, 2022
Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh
Recruiting
- Recurrent Head and Neck Cancer
- Carcinoma, Squamous Cell of Head and Neck
- Reirradiation
- MK-3475
-
Baltimore, Maryland
- +3 more
Mar 25, 2022
Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Oropharynx Squamous Cell Carcinoma
- Nivolumab Injection
- Radiotherapy (RT)
-
Atlanta, Georgia
- +2 more
Mar 24, 2022
Head and Neck Tumors, Carcinoma, Squamous Cell of Head and Neck, Metastasis Trial in Hospitalet de Llobregat, Barcelona (VCN-01,
Active, not recruiting
- Head and Neck Neoplasms
- +3 more
- VCN-01
- Durvalumab
-
Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Mar 25, 2022
Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United
Terminated
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- ilixadencel
- Pembrolizumab
-
Coral Gables, Florida
- +4 more
Mar 1, 2022
Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in
Completed
- Carcinoma, Squamous Cell of Head and Neck
- +5 more
- BKM120
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 24, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in San Antonio (Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A), surgery
-
San Antonio, TexasCancer Therapy and Research Center at UTHSCSA
Dec 15, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Afatinib, Palbociclib, standard of care)
Recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Afatinib
- +6 more
-
Antwerp, Belgium
- +35 more
Nov 22, 2021
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell of Head and Neck Trial in Essen
Active, not recruiting
- Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Carcinoma, Squamous Cell of Head and Neck
- Nivolumab and Ipilimumab
- Docetaxel
-
Essen, GermanyEssen University Hospital
Nov 25, 2021
Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,
Active, not recruiting
- Melanoma (Skin)
- +3 more
- CV8102
- CV8102 + anti-PD-1 therapy
-
Graz, Austria
- +21 more
Nov 3, 2021
Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck Trial in New York (Intraarterial Cetxuimab (Erbitux))
Terminated
- Carcinoma, Squamous Cell
- Carcinoma, Squamous Cell of Head and Neck
- Intraarterial Cetxuimab (Erbitux)
-
New York, New YorkLenox Hill Hospital
Oct 27, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CetuGEX™, Cetuximab, Chemotherapy)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- CetuGEX™
- +2 more
-
Antwerp, Belgium
- +33 more
Oct 4, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in Amsterdam (Blood draw)
Active, not recruiting
- Carcinoma, Squamous Cell of Head and Neck
- Blood draw
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Aug 3, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- AZD1775
- +2 more
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jun 27, 2021
Carcinoma, Squamous Cell of Head and Neck Trial in France (Copanlisib, Cetuximab)
Terminated
- Carcinoma, Squamous Cell of Head and Neck
-
Angers, France
- +6 more
Mar 24, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
Carcinoma, Squamous Cell of Head and Neck Trial in Amsterdam (avelumab, radiotherapy, cetuximab)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- avelumab
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Dec 10, 2019
Carcinoma, Squamous Cell of Head and Neck Trial in United States (VTX-2337, Carboplatin, Cisplatin)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- VTX-2337
- +4 more
-
Little Rock, Arkansas
- +52 more
Oct 11, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019